Amneal invests in the best quality facilities, equipment, technology and talent to ensure the seamless production of high-quality products.
A few of its more complex capabilities include long-acting depot technology for injectable products and microsphere/multiparticulate based development and scale-up. The company has mastered lyopholization, both at lab and commercial scales, as well as hot-melt extrusion and solid dispersion-based dosage forms, and continues to refine its processes across its manufacturing operations.
Amneal teams at every United States and India facility strictly follow 100% cGMP and operate in full compliance with U.S. regulatory agencies, including FDA, EPA, OSHA and DEA. Similarly, all other international sites meet or exceed the standards set by their corresponding regulatory agencies.